CNR Institutional Research Information System

IOMMELLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.631
NA - Nord America 1.111
EU - Europa 470
SA - Sud America 241
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 16
OC - Oceania 1
Totale 3.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.033
SG - Singapore 635
CN - Cina 335
HK - Hong Kong 270
BR - Brasile 181
IT - Italia 177
VN - Vietnam 131
FR - Francia 94
JP - Giappone 58
BD - Bangladesh 57
KR - Corea 57
NL - Olanda 55
CA - Canada 39
FI - Finlandia 35
DE - Germania 30
GB - Regno Unito 26
AR - Argentina 21
IN - India 21
EC - Ecuador 16
MX - Messico 14
CO - Colombia 12
ES - Italia 12
ID - Indonesia 8
IQ - Iraq 8
IL - Israele 7
RU - Federazione Russa 7
TR - Turchia 7
ZA - Sudafrica 7
CR - Costa Rica 6
IE - Irlanda 5
PH - Filippine 5
UA - Ucraina 5
JO - Giordania 4
KH - Cambogia 4
UZ - Uzbekistan 4
AT - Austria 3
LV - Lettonia 3
MN - Mongolia 3
MY - Malesia 3
PL - Polonia 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CL - Cile 2
CZ - Repubblica Ceca 2
HN - Honduras 2
JM - Giamaica 2
MA - Marocco 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
SE - Svezia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
VC - Saint Vincent e Grenadine 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
IM - Isola di Man 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
TH - Thailandia 1
Totale 3.470
Salva come PNG Salva come JPEG
Città #
Singapore 399
Santa Clara 292
Hong Kong 268
San Jose 118
Hefei 115
Beijing 90
Ashburn 83
Lauterbourg 68
Naples 64
Seoul 57
Tokyo 50
Ho Chi Minh City 47
Hanoi 33
Los Angeles 31
Chicago 27
New York 24
São Paulo 18
Lappeenranta 17
Frankfurt am Main 15
Helsinki 14
Casandrino 13
Buffalo 12
Rome 11
Council Bluffs 9
Milan 9
Dallas 8
Atlanta 7
Brooklyn 7
Orem 7
Philadelphia 7
Belleville 6
Bengaluru 6
Boardman 6
Da Nang 6
Mexico City 6
Minamishinagawa 6
Phoenix 6
Rio de Janeiro 6
Baltimore 5
Belo Horizonte 5
Des Moines 5
Dublin 5
Guayaquil 5
Hangzhou 5
London 5
Miami 5
Amsterdam 4
Baghdad 4
Buenos Aires 4
Carapicuíba 4
Columbus 4
Crowley 4
Düsseldorf 4
Ercolano 4
Istanbul 4
Las Vegas 4
Montreal 4
Newark 4
Phnom Penh 4
Poplar 4
Porto Alegre 4
Quito 4
Salvador 4
Shanghai 4
Tashkent 4
Toronto 4
Turku 4
Amman 3
Biên Hòa 3
Boston 3
Brasília 3
Can Tho 3
Chennai 3
Dhaka 3
Duque de Caxias 3
Ha Long 3
Haiphong 3
Johannesburg 3
Keyport 3
Killeen 3
Lancaster 3
Munich 3
Paris 3
Phủ Lý 3
Queens 3
Riga 3
Seattle 3
Turin 3
Ulan Bator 3
Virginia Beach 3
Vitória da Conquista 3
Washington 3
Abbeville 2
Abidjan 2
Abingdon 2
Alajuela 2
Aurora 2
Baku 2
Bauru 2
Bloomfield 2
Totale 2.183
Salva come PNG Salva come JPEG
Nome #
Monitoring Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by 18F-FLT PET/CT 97
Early reduction of 18F-FDG uptake in non-small lung cancer treated with EGFR tyrosine kinase inhibitors reflects reversal of Warburg effect and reactivation of oxidative phosphorylation. 92
Changes of Glycolytic Pathway in Response to Efficient Inhibition of EGFR Signaling in Non-small Cell Lung Cancer (NSCLC) 90
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study 80
18F-FLT PET/CT imaging and inhibition of multiple signaling pathways downstream EGFR and MET receptors in resistant NSCLC 79
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 79
Molecular mechanisms of decreased aerobic glycolysis in non-small lung cancer treated with EGFR tyrosine kinase inhibitors. European Society for Molecular Imaging Meeting 77
18F-FLT PET/CT for Detection of Functional Cross-talk between MET and EGFR in Non-small Cell Lung Cancer Resistant to EGFR Inhibitors 74
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors 72
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by F-18-fluorothymidine 70
Gefitinib, a selective, tyrosine kinase inhibitor increases 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells. 68
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention-Exploring the State of the Art 67
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 66
Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy 65
Multimodal imaging of tumor invasion by targeting integrin ?v?3 in a preclinical model of lung metastasis 64
Changes of glycolytic pathway and upregulation of oxidative phosphorylation in BCR-ABL-driven human leukemia cells treated with imatinib 61
Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER–Mitochondria Interface in Oncogene-Driven NSCLC 61
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells 59
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 59
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer 59
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 58
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 58
A reversible shift of driver dependence from egfr to notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors 58
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer 58
Preclinical imaging for targeting cancer immune evasion 57
Dynamic roles of neutrophil extracellular traps in cancer cell adhesion and activation of Notch 1-mediated epithelial-to-mesenchymal transition in EGFR-driven lung cancer cells 53
Preclinical Imaging in Targeted Cancer Therapies 51
Notch1-dependent targets in cancer stem cell resistance to EGFR inhibitors in oncogene-driven non-small cell lung cancer 48
Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells 48
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer. 48
Molecular imaging of drug resistance in cancer 47
Monitoring the effects of combined treatment with EGFR and MET inhibitors in non-small cell lung cancer and synergy quantification by 18F-FLT PET/CT 46
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 46
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins 46
PET/CT in cancer research: from preclinical to clinical applications 45
99mTc-MIBI in the evaluation of breast cancer biology 44
18F-FLT PET/CT imaging of inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer 43
Preclinical imaging in oncology: advances and perspectives 42
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 41
Early F-18-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 41
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 41
18F-FLT PET/CT as a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 40
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System 39
Evaluation of experimental pulmonary metastases in murine models by x-ray micro-computed tomography 39
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 37
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer 35
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer. 35
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 35
99mTc-MIBI in the evaluation of breast cancer biology 34
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 34
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 33
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 33
MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide 32
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-X-L modulation of inositol trisphosphate receptor type 3 32
18F-FLT PET/CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC 32
Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer 31
A RADIOLABELING SYNTHESIS OF RGD ECHI WITH 18FLUORIDE- 31
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 31
Neutrophil extracellular traps as drivers of epithelial-mesenchymal transition in cancer cells 31
Stato dell'arte dell'imaging preclinico in oncologia 31
Effect of Soluble Factors Released from Porcine Freeze-Dried Lung Tissue (FDLT) on Modulation of Cell Growth and EMT Signature in Non-Small Cell Lung Cancer (NSCLC)—A Preliminary In Vitro Study 30
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer 30
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer 30
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 30
18F-FLT PET/CTas a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 30
Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. 29
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 29
[18]F-FLT PET-CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC. 28
Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells 28
Molecular imaging of tumor microenvironment: challenges and perspectives 27
PET/CT in cancer research: from preclinical to clinical applications 26
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 26
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 25
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 24
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC 24
Addition of metformin to anti-PD-1/PD-L1 drugs activates antitumor immune response in peripheral immune cells of NSCLC patients 22
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood 15
Totale 3.556
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.630
article - articoli 9.488
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 266
Totale 21.384
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202445 0 0 0 0 0 0 0 0 4 13 13 15
2024/20251.214 14 13 106 58 293 51 14 73 59 79 239 215
2025/20261.900 95 151 121 204 430 105 281 78 149 125 79 82
2026/2027397 114 114 169 0 0 0 0 0 0 0 0 0
Totale 3.556